Literature DB >> 18367579

Evaluation of rubella virus immunoglobulin G (IgG) and IgM assays with the new Vidia instrument.

Maria Cristina Medici1, Monica Martinelli, Valeria Albonetti, Carlo Chezzi, Giuseppe Dettori.   

Abstract

For rubella virus immunoglobulin G (IgG) and IgM detection, Vidia assays were compared to Vidas, AxSYM, and Liaison assays with 419 serum samples. Only Vidia produced a sensitivity of 100% for IgG and IgM. Vidia specificities were 98.4% for IgG and 99.8% for IgM, versus Vidas specificities of 100 and 99.3%. Vidia IgG and IgM assays performed equally well.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18367579      PMCID： PMC2395110          DOI： 10.1128/JCM.00468-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Comparison of immulite with vidas for detection of infection in a low-prevalence population of pregnant women in The Netherlands.

Authors:  F Vlaspolder; P Singer; A Smit; R J Diepersloot
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  Antenatal screening for hepatitis B and antibodies to Toxoplasma gondii and rubella virus: evaluation of two commercial immunoassay systems.

Authors:  R J Diepersloot; H Dunnewold-Hoekstra; J Kruit-Den Hollander; F Vlaspolder
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

3.  Evaluation of three immunoassays used for detection of anti-rubella virus immunoglobulin M antibodies.

Authors:  Wayne Dimech; Lena Panagiotopoulos; Joan Marler; Nicolas Laven; Susan Leeson; Elizabeth M Dax
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

4.  Comparison of four enzyme immunoassays for detection of immunoglobulin M antibodies against rubella virus.

Authors:  L Matter; M Gorgievski-Hrisoho; D Germann
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

5.  Evaluation of rubella IgM enzyme immunoassays.

Authors:  Graham A Tipples; Rasool Hamkar; Talat Mohktari-Azad; Michael Gray; Jennifer Ball; Carol Head; Samuel Ratnam
Journal:  J Clin Virol       Date:  2004-07       Impact factor: 3.168

6.  Persistence of specific IgM and low avidity specific IgG1 following primary rubella.

Authors:  H I Thomas; P Morgan-Capner; G Enders; S O'Shea; D Caldicott; J M Best
Journal:  J Virol Methods       Date:  1992-09       Impact factor: 2.014

7.  Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella: implications for diagnosis and immunopathology.

Authors:  H I Thomas; P Morgan-Capner; J E Cradock-Watson; G Enders; J M Best; S O'Shea
Journal:  J Med Virol       Date:  1993-11       Impact factor: 2.327
  7 in total
  3 in total

1.  Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays.

Authors:  Wayne Dimech; Nilukshi Arachchi; Jingjing Cai; Terri Sahin; Kim Wilson
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

2.  Performance of the Elecsys Rubella IgG assay in the diagnostic laboratory setting for assessment of immune status.

Authors:  Martin Enders; Uwe Bartelt; Frank Knotek; Kristina Bunn; Sirpa Strobel; Klaus Dietz; Gisela Enders
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

Review 3.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.